银河证券北交所日报-20260327

Core Insights - The report highlights the performance of the Beijing Stock Exchange (BSE) on March 27, 2026, with the BSE 50 index closing at 1,271.41 points, reflecting a change of +0.37% [1] - The overall trading volume on the BSE was 10.72 billion yuan, with a total of 523 million shares traded, indicating a decrease compared to the previous week's average daily trading volume of 15.91 billion yuan [1] - The report notes that the majority of industries on the BSE experienced gains, particularly the pharmaceutical and biological sector, which rose by 7.5% [1] - The overall valuation of BSE-listed companies was reported at a price-to-earnings (P/E) ratio of 39.42 times, which is lower than that of the Sci-Tech Innovation Board and the ChiNext [1][8] Industry Performance - On March 27, 2026, the pharmaceutical and biological industry led the gains with an increase of 7.5%, followed by food and beverage (+1.7%) and construction materials (+1.6%) [1] - The sectors that experienced declines included oil and petrochemicals (-1.8%), utilities (-1.7%), and media (-1.6%) [1] - The report provides a detailed breakdown of the top-performing stocks, with the leading stock, Puan Medical, increasing by 136.56% [6] Stock Performance - Among the 301 listed companies on the BSE, 181 saw their stock prices rise, while 115 experienced declines [1] - The report lists the top ten stocks by daily gain, with Puan Medical leading at +136.56%, followed by Haiseng Medical (+9.72%) and Tianhong Lithium (+5.72%) [6] - Conversely, the top ten stocks by daily loss included *ST Yunchuang (-5.21%), Huayang Transmission (-4.27%), and Oputai (-3.65%) [7] Valuation Insights - The report indicates that the overall valuation of BSE-listed companies has rebounded, with a P/E ratio of approximately 39.42 times [1] - The highest average P/E ratio among sectors was noted in oil and petrochemicals at 113.2 times, followed by non-ferrous metals (94.1 times) and telecommunications (77.2 times) [8]